Pharmacist-Delivered Program for Smoking Cessation

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Medical University of South Carolina
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to help people living with HIV quit smoking through a new program that involves pharmacists more directly in tobacco treatment. The program, ENHANCE-TTS, equips pharmacists with tools and training to deliver smoking cessation services effectively. The trial will evaluate the program's effectiveness in helping patients stop smoking and identify any challenges in its implementation. Suitable participants include those living with HIV, over 21, who have consulted a clinical pharmacist for smoking cessation, and speak English. As an unphased trial, this study offers a unique opportunity to contribute to innovative approaches in smoking cessation for people living with HIV.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.

What prior data suggests that the ENHANCE-TTS program is safe?

Research has shown that team-based programs to help people quit smoking, such as ENHANCE-TTS, are generally safe and manageable. One study on a similar program found that involving pharmacists and tobacco treatment counselors helped more people quit smoking without major side effects. This finding suggests that the ENHANCE-TTS program could be a safe choice for participants. While no specific side effects have been noted for ENHANCE-TTS, the program primarily involves training and support, which are unlikely to pose safety concerns.12345

Why are researchers excited about this trial?

Researchers are excited about the ENHANCE-TTS program because it represents a fresh approach to smoking cessation by actively involving pharmacists in the treatment process. Unlike traditional methods that often focus solely on medications or counseling, this program enhances the delivery of tobacco treatment services through team-building and specialized pharmacist training. It also provides essential tools like infrastructure planning, problem-solving, and coaching, which can lead to more personalized and effective patient care. This innovative approach could potentially increase the success rates of quitting smoking by leveraging pharmacists' accessibility and expertise in healthcare settings.

What evidence suggests that the ENHANCE-TTS program is effective for smoking cessation in people living with HIV?

Research has shown that the ENHANCE-TTS program, which involves pharmacists in smoking cessation efforts, is promising. In this trial, participants will engage with the ENHANCE-TTS program. Studies have found that when trained Tobacco Treatment Specialists participate, nearly 90% of patients set a quit date. The training they receive significantly boosts their chances of quitting. Another study found that these programs can lead to substantial success, with 25.9% of participants remaining smoke-free for eight weeks. This evidence suggests that pharmacist-led programs like ENHANCE-TTS could effectively help people quit smoking, particularly those living with HIV.23678

Who Is on the Research Team?

AR

Alana Rojewski, PhD

Principal Investigator

Medical University of South Carolina

Are You a Good Fit for This Trial?

This trial is for adults age 21 or older who have HIV, speak English, and have seen a clinical pharmacist at least once for help quitting smoking. Pharmacists, clinic administrators, and patient advocates from participating clinics can also join. People currently in prison cannot participate.

Inclusion Criteria

I am 21 years old or older.
I have been diagnosed with HIV.
Pharmacists, Clinic Administrators, and Patient Advocates from each of 6 Ryan White clinics who agree to participate in the study.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Implementation

Implementation of the ENHANCE-TTS program including team-building, pharmacist training, and facilitation

3 months
Multiple visits for training and facilitation

Follow-up

Participants are monitored for smoking abstinence and intervention outcomes

6 months
Follow-up assessments at 3 and 6 months

Study Completion

Final evaluation of intervention adoption, acceptability, fidelity, and cost

Approximately 4 years

What Are the Treatments Tested in This Trial?

Interventions

  • ENHANCE-TTS

Trial Overview

The study is testing ENHANCE-TTS—a program that gives pharmacists new tools and training to better help people with HIV quit smoking. The research looks at how well this approach works in real-world clinics.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: ENgaging pHarmacists to AdvANCE Tobacco Treatment Service delivery (ENHANCE-TTS)Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Medical University of South Carolina

Lead Sponsor

Trials
994
Recruited
7,408,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

Citations

The Evaluation of an Integrated Tobacco Treatment Specialist ...

The TTS-NP was effective in working with patients to set goal quit dates, as almost 90% of the patients succeeded in doing so. According to the United States ...

A Tobacco Treatment Training Program Expands the ...

Of those, 1,052 (91%) successfully completed the course as a Tobacco Treatment Specialist (TTS) after passing the exam. Our trainees' knowledge ...

Evaluation of a Tobacco Treatment Training Program - PMC

While there was a limited six-month response rate in this study, results showed overwhelming improvement in knowledge, confidence, and skills in ...

The effectiveness of tobacco cessation programs for ...

Eight-week prolonged abstinence was reported by 203 participants (25.9%) in the intervention group and 105 (14.6%) in the control group. 4-week ...

Enhancing hospitalists smoking cessation counseling and ...

The primary outcomes studied were the frequency of inpatient consulting to quit smoking and the physicians' billing compliance, these measures were chosen as ...

Developing a Collaborative, Team-Based Smoking Cessation ...

A team-based cessation program that leverages pharmacy and tobacco treatment counselors as clinical support specialists to treat outpatient cancer patients who ...

Evaluation of a Tobacco Treatment Training Program

The purpose of this study was to evaluate a Tobacco Treatment Specialist Training program with a pre-test and post-test (provided six months after the program)

Continuing Education Opportunities (for TTS)

This training promotes evidence-based, proven-effective cessation strategies and reviews the seven FDA-approved quit medications currently available.